According to Moody's, Global Air Passenger will last until 2023

According to Moody's Investors Service, by the end of 2023, global airline passenger demand will not exceed the pre-coronavirus virus epidemic, and only then will effective vaccines and drugs become available.

The recovery of airlines and airports will be largely aligned, after which air leaseholders will return to aircraft for service, Moody's analysts, including Jonathan Route, wrote in a report. He wrote that manufacturers such as Boeing Co and Airbus SE would be the last to reclaim their aviation industry in the direct aviation industry.

According to the report, passenger airlines supported 3% of global GDP in 2019, a decline of more than 90% at the onset of an epidemic, affecting the global scale of the epidemic.

Moody's says vaccine development is crucial in determining the industry's resilience, both fundamentally and financially, while at the same time maximizing government support to keep airlines alive.

"The effective coronavirus vaccine is not well available before 2021 - and the airline industry needs additional government support to cover the transition to the virus and ensure an adequate supply of doses to the public. .

There may also be changes in long-distance travel, with some carriers expanding point-to-point operations and others for hub-to-hub flight, trusting to complete the journey at code-share or joint venture partners.

Meanwhile, according to Moody's, the Airbus A320neo and Boeing 737 MAX are expected to reduce carbon emissions for delivery.

Post a Comment